see, axsome that's got two drugs on the market. main formulation, odell 80, is a depression treatment let's basically a combination of well beaten -- getting there was a long difficult process. they got another drag on the market that's for excessive daytime sleepiness caused by disruptive sleep apnea or narcolepsy. they bought this one from jazz pharma couple years ago. but if you're thinking about buying axsome right here, it's all about what they've got in the pipeline. the league depression drug also happens to be in trials for alzheimer's disease agitation. it's got -- fda. very important. it's also an early stage trials for smoking cessation. axsome's either drug is advanced trials for adhd, binge eating disorder, and shift work disorder. that's what they call it when you have trouble sleeping because he worked odd hours. -- an excess lash 07 which is being used as a migraine drug. -- issues with its chemistry, manufacture, and controls. they didn't rejected because of the drug safety or efficacy profile. the same time, axsom